stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

CPH Group AG

Switzerland · SIX: CPH.CO · Market cap: · P/E: · P/S:

CPH Group makes specialty chemicals and pharmaceutical packaging, selling them to drug makers and industrial customers.

CPH Group is a Swiss industrial company with two very different jobs. One side makes specialty chemicals — mainly packaging papers and films used for things like labels and tapes. The other side makes pharmaceutical packaging, the materials that keep medicines safe and clean on their way to patients. Both businesses sell to other companies, not to shoppers. Drug manufacturers and industrial firms are the customers, and they pay for reliability: packaging that meets strict rules, and papers that perform exactly the same way batch after batch.

The chemicals business is the bigger, steadier engine. It makes specialty papers and films at plants in Europe, and these get used in packaging, labeling, and technical applications. This is a commodity-adjacent business, which means customers can switch suppliers if quality slips or prices rise too far. CPH competes on precision and consistency rather than flashy innovation. Its pharmaceutical packaging arm is smaller but more specialized: it makes films and materials that protect pills and other medicines, a niche where regulation creates a moat because changing a qualified supplier is slow and expensive for a drug maker. The company is headquartered in Switzerland and listed on the SIX Swiss Exchange. It has grown partly by acquiring smaller specialty businesses and folding them into its operations, a common path for mid-sized European industrials. That strategy gives it scale and geographic reach, but it also means the company carries the usual risks of a diversified industrial: exposure to manufacturing demand, energy costs, and the slow grind of European industrial growth. There is no consumer brand here, no viral product, and little drama. It is the kind of business that quietly supplies the packaging and materials behind things you never notice.


CPH's money comes from selling these materials in volume to industrial and pharmaceutical buyers. Margins depend on keeping plants running efficiently and holding prices against competitors, so management's real job is operational discipline. It is a profitable, cash-generating business, though not a fast-growing one. The honest picture is a solid niche industrial with a protected pharmaceutical segment and a more cyclical chemicals core — dependable, unglamorous, and priced for exactly that.

Saved answer · last researched 16 Nov 2026